Medication Safety

Investigating suspected tampering with medicines

11 June 2024A systematic approach should be taken to responding to reports of possible malicious tampering, securing the evidence, and seeking specialist advice and support

Including medicines with Risk Minimisation Measures (RMM) in PGDs

10 November 2025Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Implementing self-administration of medicines

18 November 2024Individuals receiving healthcare should be supported to continue to self-administer existing/new medications unless there are reasons why they are unable to

Handling injectable cytotoxic medicines in clinical areas

17 November 2025Handling of injectable cytotoxic medicines in clinical areas should take into account risks to staff

Giving intermittent intravenous infusions by gravity in adults

6 September 2024Infusion by gravity is not the preferred method of administration, but may be necessary in some circumstances. Ensure a risk assessment is undertaken.

Ensuring time critical use of rasburicase

9 September 2025Timely use of rasburicase for treatment of tumour lysis syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.

Ensuring the safe use of amphotericin B injection

25 November 2025Amphotericin B liposomal products and Fungizone are not interchangeable. Take action to prevent death caused by inadvertent mis-selection

Developing opioid safety across a system

2 June 2025Strategies and signposting to support safer use of opioids for chronic, non-cancer pain.

Developing insulin safety across a system

12 June 2025Strategies, signposting and initiatives to support safer use of insulin.

Developing Medication Safety Across The System (MSATS)

3 April 2024Medication Safety Across the System (MSATS) provides resources and networking to inspire and equip individuals in promoting the safe use of medicines.